PTK6 and breast cancer: We generated a BRV-BC enhancer with both Brk sites mutated but found no loss of silencing activity (Figure 7—figure supplement 1B–C), indicating either that Brk does not function in mediating the repression, or that its activity is redundant with other mechanisms that are still functional.